乌拉地尔与硝酸甘油在急性心源性肺水肿血压控制中的疗效与安全性比较
该前瞻性队列研究在三级大学急诊科纳入296例高血压性急性心源性肺水肿成人,比较静脉硝酸甘油(n=142)与乌拉地尔(n=154)作为初始管理的疗效与安全性。乌拉地尔自60分钟起累积血压达标率更高更早(p<0.001),收缩压/舒张压和心率早期下降更快。但乌拉地尔组有创机械通气(13.6% vs 6.3%,p=0.038)和ICU入住(55.2% vs 38.7%,p=0.010)更频繁;硝酸甘油组补救治疗更多(28.2% vs 16.9%,p=0.020),头痛更常见。作者认为优先早期临床稳定时可考虑硝酸甘油,乌拉地尔仍是合理替代。
要点
- 乌拉地尔自60分钟起累积血压达标率高于硝酸甘油(p<0.001),收缩压/舒张压和心率早期下降更快。
- 乌拉地尔组有创机械通气13.6% vs 硝酸甘油组6.3%(p=0.038),ICU入住55.2% vs 38.7%(p=0.010)。
- 硝酸甘油组补救治疗需求28.2% vs 乌拉地尔组16.9%(p=0.020)。
- 硝酸甘油组头痛更常见,其他不良事件两组相当。
- 作者认为优先早期临床稳定时可考虑硝酸甘油,乌拉地尔仍是合理替代。
适用人群与场景
- 三级大学急诊科成人高血压性急性心源性肺水肿患者,接受静脉硝酸甘油或乌拉地尔作为初始管理的一部分。
诊断标准与关键阈值
- 主要结局目标:收缩压<140 mmHg。
处置流程与药物剂量
- 静脉硝酸甘油或乌拉地尔作为初始管理,具体剂量、给药频次和疗程原文未给出。
- 基线及每30分钟记录血流动力学参数至330分钟。
研究设计与关键结果
- 前瞻性队列研究,296例患者(硝酸甘油n=142,乌拉地尔n=154;中位年龄69岁,女性51%)。
- 乌拉地尔自60分钟起累积血压达标率更高更早(p<0.001),收缩压/舒张压和心率早期下降更快。
- 有创机械通气:乌拉地尔13.6% vs 硝酸甘油6.3%(p=0.038)。
- ICU入住:乌拉地尔55.2% vs 硝酸甘油38.7%(p=0.010)。
- 补救治疗:硝酸甘油28.2% vs 乌拉地尔16.9%(p=0.020)。
- 头痛硝酸甘油更常见,其他不良事件两组相当。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在高血压性急性心源性肺水肿中,优先早期临床稳定时可考虑硝酸甘油。
- 作者认为,乌拉地尔仍是合理替代。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute cardiogenic pulmonary edema (ACPE) is a life-threatening manifestation of acute heart failure characterized by abrupt pulmonary congestion and hypertension. Rapid blood pressure (BP) reduction with intravenous vasodilators is a cornerstone of emergency management. Nitroglycerin is widely used but may be limited by side effects, while urapidil, an α1-adrenergic antagonist with additional central serotonergic activity, has been proposed as an alternative.
METHODS: In this prospective cohort study at a tertiary university emergency department, adults with hypertensive ACPE received either intravenous nitroglycerin or urapidil as part of initial management. Hemodynamic parameters were recorded at baseline and every 30 min up to 330 min. The primary outcome was achievement of target systolic BP (<140 mmHg). Secondary outcomes included time-resolved changes in systolic/diastolic BP and heart rate, need for rescue therapy, mechanical ventilation, disposition, and adverse events.
RESULTS: A total of 296 patients were analyzed (nitroglycerin n = 142, urapidil n = 154; median age 69 years, 51 % female). Urapidil achieved earlier and higher cumulative attainment of the BP target from 60 min onward (p < 0.001) and produced faster early declines in systolic/diastolic BP and heart rate. However, invasive mechanical ventilation (13.6 % vs. 6.3 %, p = 0.038) and intensive care admissions (55.2 % vs. 38.7 %, p = 0.010) were more frequent with urapidil. Rescue therapy was required more often with nitroglycerin (28.2 % vs. 16.9 %, p = 0.020). Headache occurred more frequently with nitroglycerin, while other adverse events were comparable.
CONCLUSION: In hypertensive ACPE, urapidil reaches blood pressure targets in a more timely manner, but may be associated with higher rates of endotracheal intubation and ICU admission in this cohort. These observations may support consideration of nitroglycerin when early clinical stabilization is prioritized, while urapidil remains a reasonable alternative. Safety profiles were broadly similar, aside from more frequent headaches with nitroglycerin.
参考来源
- Yakin F, Unal E, Altun M, et al. Comparative efficacy and safety of urapidil and nitroglycerin for blood pressure control in acute cardiogenic pulmonary edema. Am J Emerg Med. 2025. PMID: 41167008. doi:10.1016/j.ajem.2025.10.041
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。